(Q49107453)

English

Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

0 references

(E)-phytonadione

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Daniela Quaglino

object named as

Daniela Quaglino

4

0 references

author name string

Olivier M Vanakker

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Ludovic Martin

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Leon J Schurgers

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Laura Costrop

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Ivonne Pasquali-Ronchetti

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Paul J Coucke

8

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Anne De Paepe

9

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

publication date

5 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Laboratory Investigation

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

90

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

895-905

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.68

0 references

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Vascular smooth muscle cells and calcification in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Biochemical characterization of the serum fetuin-mineral complex

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Processing and transport of matrix gamma-carboxyglutamic acid protein and bone morphogenetic protein-2 in cultured human vascular smooth muscle cells: evidence for an uptake mechanism for serum fetuin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Haemorrhagic disease of the newborn: a review of 127 cases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Low vitamin K status is associated with osteoarthritis in the hand and knee

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Novel clinico-molecular insights in pseudoxanthoma elasticum provide an efficient molecular screening method and a comprehensive diagnostic flowchart.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Tissue-specific expression of the ABCC6 gene.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Pseudoxanthoma elasticum: reduced gamma-glutamyl carboxylation of matrix gla protein in a mouse model (Abcc6-/-).

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Mutations in the GGCX and ABCC6 genes in a family with pseudoxanthoma elasticum-like phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Matrix GLA protein function in human trabecular meshwork cells: inhibition of BMP2-induced calcification process

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Cloning and targeted deletion of the mouse fetuin gene

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Multifunctional Roles for Serum Protein Fetuin-A in Inhibition of Human Vascular Smooth Muscle Cell Calcification

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Does the absence of ABCC6 (multidrug resistance protein 6) in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

21 January 2018

Pharmacogenomics of 4-hydroxycoumarin anticoagulants

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

7 January 2021

based on heuristic

inferred from DOI database lookup

The local calcification inhibitor matrix Gla protein in pseudoxanthoma elasticum

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolism and cell biology of vitamin K

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical characterization of elastofibroma and exclusion of ABCC6 as a predisposing gene

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.68

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LABINVEST.2010.68

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/20368697

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49107453&oldid=1584999584"